Is active surveillance safe for men with family history of prostate cancer?
Reuters: Health News
(Reuters Health) - Having a family history of prostate cancer doesn’t make it more risky for men with a new diagnosis of the disease to initially hold off on active treatment in favor of monitoring with periodic lab tests, a research review suggests.
NEW YORK (Reuters) - Health insurers seeking regulatory approval for 2018 individual insurance plans can file two sets of premium rates as a way to deal with market uncertainty created by Republicans' promise to repeal and replace Obamacare, a California state insurance regulator said on Friday.
(Reuters Health) - Instead of eating less saturated fat and worrying about so-called bad cholesterol, a group of doctors suggests an alternative approach for preventing heart disease.
(Reuters Health) - Elderly people with hearing loss may have difficulty understanding speech in noisy healthcare settings - and the situation isn't helped when doctors speak fast and use medical jargon, experts say.
(Reuters) - The U.S. Food and Drug Administration approved Novartis AG's Rydapt as an initial treatment for acute myeloid leukemia (AML) as well as certain other blood disorders, the agency said on Friday.
No comments:
Post a Comment